| Identification | Back Directory | [Name]
Acetamide, N-[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]-2-(2-hydroxyethoxy)- | [CAS]
2920907-39-5 | [Synonyms]
Acetamide, N-[(1S,9S)-9-ethyl-5-fluoro-2,3,9,10,13,15-hexahydro-9-hydroxy-4-methyl-10,13-dioxo-1H,12H-benzo[de]pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-1-yl]-2-(2-hydroxyethoxy)- | [Molecular Formula]
C28H28FN3O7 | [MOL File]
2920907-39-5.mol | [Molecular Weight]
537.54 |
| Hazard Information | Back Directory | [Uses]
Exatecan-amide-CH2-O-CH2-CH2-OH (Compound 4) is a derivative of Exatecan (HY-13631). Exatecan-amide-CH2-O-CH2-CH2-OH can be used for the research of cell proliferative diseases such as cancer[1]. | [IC 50]
Camptothecins | [References]
[1] Pan FJ, et al. Camptothecin derivatives and uses thereof. CN115850291A. 2023-03-28. |
|
|